Antipsychotic-Induced QT Prolongation and Torsade de Pointes in Patients with Mental Disorders: A Review
INTRODUCTION. The high risk of life-threatening ventricular arrhythmias, particularly Torsade de Pointes (TdP), makes QT prolongation one of the most significant adverse drug reactions (ADRs) due to cardiotoxicity associated with antipsychotics (APs). AIM. This study aimed to systematise information...
Saved in:
Main Authors: | R. F. Nasyrova (Author), A. V. Kidyaeva (Author), M. M. Petrova (Author), N. A. Shnayder (Author) |
---|---|
Format: | Book |
Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Case of Ciprofloxacin-Induced QT Prolongation and Torsade de Pointes
by: Hedieh Keshavarz-Bahaghighat, et al.
Published: (2017) -
Cholinesterase inhibitors-associated torsade de pointes/QT prolongation: a real-world pharmacovigilance study
by: Ni Zhang, et al.
Published: (2024) -
Drug-induced QT prolongation and torsade de pointes: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database
by: Dongxuan Li, et al.
Published: (2023) -
Antipsychotic-Induced Parkinsonism: A Risk Assessment Scale and Personalised Diagnosis Algorithm
by: N. A. Shnayder, et al.
Published: (2022) -
Torsade de Pointes/QT Prolongation Associated with Antifungal Triazoles: A Pharmacovigilance Study Based on the U.S. FDA Adverse Event Reporting System(FAERS)
by: Zicheng Yu, et al.
Published: (2022)